High-dose cisplatin with sodium thiosulfate protection.
- 1 February 1985
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 3 (2), 237-244
- https://doi.org/10.1200/jco.1985.3.2.237
Abstract
Nephrotoxicity frequently limits the dose of cisplatin to less than 120 mg/m2 per injection. Sodium thiosulfate is a neutralizing agent for cisplatin that protects against renal damage. To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin. Cisplatin was administered over the last two hours of the thiosulfate infusion. Using this technique, it was possible to escalate the cisplatin dose to 225 mg/m2 before dose-limiting toxicities were encountered. Comparison of cisplatin pharmacokinetics in patients treated with 202.5 mg/m2 plus thiosulfate to those in patients treated with 100 mg/m2 without thiosulfate indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of cisplatin. The total drug exposure for the plasma was approximately twofold at the higher cisplatin dose. Thi...This publication has 5 references indexed in Scilit:
- High-Dose Cisplatin in Hypertonic SalineAnnals of Internal Medicine, 1984
- Clinical pharmacokinetics of intraarterial cisplatin in humans.Journal of Clinical Oncology, 1983
- INTRAPERITONEAL CIS-DIAMMINEDICHLOROPLATINUM WITH SYSTEMIC THIOSULFATE PROTECTION1983
- Intraperitoneal Cisplatin with Systemic Thiosulfate ProtectionAnnals of Internal Medicine, 1982
- MECHANISM OF CIS-PLATINUM NEPHROTOXICITY .1. EFFECTS OF SULFHYDRYL-GROUPS IN RAT KIDNEYS1980